Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
about
Therapeutic Lymphoid Organogenesis in the Tumor Microenvironmentp53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cellsCXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasisQuantifying differential gene connectivity between disease states for objective identification of disease-relevant genes.The emerging role of CXC chemokines and their receptors in cancer.Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinoma.CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisTranscriptome-wide signatures of tumor stage in kidney renal clear cell carcinoma: connecting copy number variation, methylation and transcription factor activity.A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancerInformative gene selection and the direct classification of tumors based on relative simplicity.The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate CancerLocal production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution.CXCL13 is a plasma biomarker of germinal center activity.Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis.CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphomaCD4⁺ follicular helper T cell infiltration predicts breast cancer survivalMDC and BLC are independently associated with the significant risk of early stage lung adenocarcinoma.Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissueSurface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.Potential role of CXCR3 in proliferation and invasion of prostate cancer cellsCXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.Molecular and clinicopathological markers of prognosis in breast cancer.Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived CancersThe Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt SignalingCXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasionA multiplex platform for the identification of ovarian cancer biomarkersStructured Learning of Gaussian Graphical ModelsGenomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice.Signaling via the CXCR5/ERK pathway is mediated by CXCL13 in mice with breast cancer.
P2860
Q26799123-4C0624E7-DDE3-451C-B41A-1C97EF435974Q28259090-F0E2A30F-1108-4482-9E98-A6A0B0947B46Q28304012-7D772B64-183D-4F36-9272-BDD917202769Q33917439-023B4E16-5362-40C6-93AA-F70DF2B3A9A8Q34263645-A4F1188F-98D6-4074-B535-3E1894EA5399Q34432823-E3EA75C1-3773-41E3-9222-D876436E0712Q34654463-6A618B68-C0AC-443A-A4EA-AC59AF409F6FQ34940432-A580F76F-84D1-4AC1-8B5A-4A0AD3FCEBFDQ34989150-9E1C3464-982E-47AB-BAE7-387B643B6753Q35754593-BAB56BEC-5601-4A14-B374-C2159C4F1B67Q35899607-5BAF29B1-3278-4E2B-96C1-9F32A80103A3Q36274988-AFDED129-E386-4D7F-8511-53C7C23C86BAQ36413088-D25E6CB7-CC0A-478B-9F19-A74FF06EA145Q36610052-0C661A41-4BA3-4366-B3DE-0F913214FF45Q36684710-4CF21475-270C-4BB9-87C7-49EB390F1D52Q36742625-9581E85A-984F-41EB-88F4-2FED8A4890D0Q36907849-ACE2B25A-8715-49D8-87A1-C2E691553443Q36966923-4697D2BF-638C-48E4-AB20-744F68CF9FE0Q37696264-B411D31A-D210-4705-9E40-0535AE9E1C66Q37696662-B1727987-5FAF-4950-A004-D168881BBF6FQ38620978-8734A30E-2FB3-4809-84DF-AA6D76D010AAQ38828754-69CCF0EA-9545-445C-85E6-838698C03FC8Q38837940-ADB1045A-E6CC-4A92-9BA9-F279DFF135F3Q38932126-05C821D5-4F6D-422B-90B8-41E68D241436Q39399933-4516E3A7-40A7-491B-A89C-51065444926CQ41457800-870F0BC1-532F-4A17-B28B-3F0FA2C9EB19Q41573243-1F710BB9-5F34-40BE-A291-F843798315B7Q41593121-33365770-8F33-4F06-9D76-D1651C5080BCQ42374131-A36E78B4-E518-4E64-BE54-02B4ADE1E729Q42691135-99AD06EB-075B-4015-B6DE-F14838DFB690Q47739176-95E6BC85-6EDB-446E-8D71-267A8FF1A48CQ52724857-260F04E1-6BB7-4950-A08A-FEB29E5BEFB6Q54977788-8C48EFD6-7DD9-4E00-94AD-AA0FCF830A28
P2860
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Chemokine CXCL13 is overexpres ...... ood of breast cancer patients.
@en
type
label
Chemokine CXCL13 is overexpres ...... ood of breast cancer patients.
@en
prefLabel
Chemokine CXCL13 is overexpres ...... ood of breast cancer patients.
@en
P2093
P2860
P356
P1476
Chemokine CXCL13 is overexpres ...... ood of breast cancer patients.
@en
P2093
A Niendorf
C Bokemeyer
D Atanackovic
K Friedrichs
K Milde-Langosch
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604621
P407
P577
2008-09-01T00:00:00Z